Standard Biotools LAB
NASDAQ LAB
$0.71 +0.06 (+9.23%)
At close: Nov 13, 2026 · 4:00 PM EST

Standard Biotools (LAB) Long-Term Deferred Tax (2023 - 2026)

Updated

Standard Biotools' Long-Term Deferred Tax was $273,000 in Q3 2026, up 3.4% from the prior quarter.

Analysis

Standard Biotools (LAB) Long-Term Deferred Tax (2023 - 2026) Analysis & Trends

At the end of FY2025, Long-Term Deferred Tax at Standard Biotools came in at $38.63 million.

  • In earlier years, Long-Term Deferred Tax was $138,000 in FY2024.
  • Quarterly Long-Term Deferred Tax has moved between $138,000 (Q4 2024) and $38.63 million (Q4 2025) over five years.
  • Per Business Quant data, LAB's Long-Term Deferred Tax in the three quarters before Q3 2026 was $264,000 (Q2 2026), $270,000 (Q1 2026) and $38.63 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Standard Biotools 280.22 Mn -1.30 Bn 10.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 273,000.00
Jun 30, 2026 264,000.00
Mar 31, 2026 270,000.00
Dec 31, 2025 38.63 Mn
Jun 30, 2025 384,000.00
Mar 31, 2025 390,000.00
Dec 31, 2024 138,000.00
Dec 31, 2023 98,000.00
API Access

Standard Biotools Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=LAB&period=max&api_key=YOUR_API_KEY